Study S002146

An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT02962492
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: TRIPLE
Status: COMPLETED
Enrollment: 70
Start: 2016-11-01
Primary completion: 2021-02-01
Lead sponsor: University at Buffalo
Conditions: Evaluate Ketogenic Stress
Interventions: DRUG:Exenatide/Exenatide extended release; DRUG:Dapagliflozin; DRUG:Placebo
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Change in Beta-hydroxybutyrate Levels in Blood [12 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.